Breaking News Instant updates and real-time market news.

EXAS

Exact Sciences

$18.57

0.89 (5.03%)

12:35
10/03/16
10/03
12:35
10/03/16
12:35

Exact Sciences reports inclusion of Cologuard in HEDIS quality measures

Exact Sciences Corp. announced that Cologuard is now included in the 2017 Healthcare Effectiveness Data and Information Set, or HEDIS, quality measures for colorectal cancer screening. The new quality measures were published by the National Committee for Quality Assurance. More than 90% of America's health plans measure quality based on HEDIS.

  • 04

    Oct

  • 26

    Oct

  • 15

    Nov

EXAS Exact Sciences
$18.57

0.89 (5.03%)

08/10/16
BARD
08/10/16
NO CHANGE
BARD
Outperform
HCSC coverage of Cologuard could pressure other payors, says Baird
Baird analyst Catherine Ramsey noted that Health Care Service Corporation, or HCSC, which is the nation's largest customer-owned health insurance company as the owner of several Blue Cross and Blue Shield systems, has posted a pending medical policy that would provide coverage for Exact Sciences' Cologuard. Coverage of the test by HCSC would be a "significant win" and could help pressure other payors to update their policies, said Ramsey, who keeps an Outperform rating on Exact Sciences shares.
08/10/16
CHLM
08/10/16
NO CHANGE
Target $26
CHLM
Buy
Craig-Hallum positive on HCSC, Florida Blue coverage of Exact Sciences Cologuard
Craig-Hallum analyst Bill Bonello notes that two payors, namely Health Care Service Corporation, or HCSC, and Florida Blue posted updated Medical Policies indicating that Exact Sciences' Cologuard may be "medically necessary" for colorectal cancer screening. The analyst believes this is a "very positive" indicator of how other payors will interpret the positive recommendation from the U.S. Preventive Services Task Force issued in June. Further, he sees Exact Sciences as well positioned to become standard of care for colon cancer screening, which could be a $3B-$5B opportunity over time. Bonello reiterates a Buy rating and $26 price target on the shares.
08/15/16
ADAM
08/15/16
NO CHANGE
Target $24
ADAM
Buy
Exact Sciences price target raised to $24 from $19 at Canaccord
Canaccord analyst Mark Massaro raised his price target on Exact Sciences to $24 from $19 citing expectations of ongoing commercial momentum in the second half of the year coupled with new commercial payor wins. Massaro raised its numbers based on recent payor wins and the belief Q3 guidance feels achievable. Massaro reiterated his Buy rating on Exact Sciences shares.
09/01/16
CHLM
09/01/16
NO CHANGE
Target $26
CHLM
Buy
Exact Sciences Cologuard to receive commercial payor coverage, says Craig-Hallum
After eviCore suggested that Exact Sciences' Cologuard may be considered for colorectal cancer screening once every three years, Craig-Hallum analyst Bill Bonello says he believes that at least one large health insurer, Highmark, has already elected to follow this policy. The analyst continues to believe that Cologuard will receive broad commercial payer coverage in light of the 2016 USPSFT final colorectal cancer screening recommendation and that increased payer coverage will drive increased test volumes. He reiterates a Buy rating and $26 price target on the shares.

TODAY'S FREE FLY STORIES

CO

China Cord Blood

$11.71

-0.33 (-2.74%)

, MRNS

Marinus Pharmaceuticals

$4.16

-0.15 (-3.48%)

08:30
09/21/17
09/21
08:30
09/21/17
08:30
Options
Three new option listings on September 21st »

New option listings for…

CO

China Cord Blood

$11.71

-0.33 (-2.74%)

MRNS

Marinus Pharmaceuticals

$4.16

-0.15 (-3.48%)

SENS

Senseonics

$3.05

0.02 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHL

Scholastic

$38.51

-0.03 (-0.08%)

08:30
09/21/17
09/21
08:30
09/21/17
08:30
Technical Analysis
Technical View: Scholastic down on wider loss and outlook »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

08:30
09/21/17
09/21
08:30
09/21/17
08:30
General news
U.S. Philly Fed index preview: »

U.S. Philly Fed index…

ALL

Allstate

$91.38

0.24 (0.26%)

08:28
09/21/17
09/21
08:28
09/21/17
08:28
Hot Stocks
Allstate reports August catastrophe loss estimate of $593M »

Allstate reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

HSIC

Henry Schein

$80.39

1.25 (1.58%)

, PDCO

Patterson Companies

$37.82

0.64 (1.72%)

08:28
09/21/17
09/21
08:28
09/21/17
08:28
Initiation
Henry Schein, Patterson Companies initiated  »

Henry Schein initiated…

HSIC

Henry Schein

$80.39

1.25 (1.58%)

PDCO

Patterson Companies

$37.82

0.64 (1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:25
09/21/17
09/21
08:25
09/21/17
08:25
General news
N.Y. FX Outlook »

N.Y. FX Outlook:…

BCRX

BioCryst

$5.27

-0.16 (-2.95%)

08:22
09/21/17
09/21
08:22
09/21/17
08:22
Technical Analysis
Technical View: BioCryst up on FDA news concerning Rapivab »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

MU

Micron

$35.97

0.02 (0.06%)

08:22
09/21/17
09/21
08:22
09/21/17
08:22
Recommendations
Micron analyst commentary  »

Micron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

$DJT

DJ Transportation Average

08:21
09/21/17
09/21
08:21
09/21/17
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETR

Entergy

$77.80

-0.25 (-0.32%)

08:21
09/21/17
09/21
08:21
09/21/17
08:21
Upgrade
Entergy rating change  »

Entergy upgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 05

    Nov

$DJU

DJ Utility Average

08:21
09/21/17
09/21
08:21
09/21/17
08:21
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

08:21
09/21/17
09/21
08:21
09/21/17
08:21
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UFI

Unifi

$32.91

0.09 (0.27%)

08:21
09/21/17
09/21
08:21
09/21/17
08:21
Conference/Events
Unifi management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

IYT

iShares Transportation Average

$174.15

2.54 (1.48%)

08:20
09/21/17
09/21
08:20
09/21/17
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$58.81

-0.24 (-0.41%)

08:20
09/21/17
09/21
08:20
09/21/17
08:20
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$66.84

0.45 (0.68%)

08:20
09/21/17
09/21
08:20
09/21/17
08:20
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$4.00

0.07 (1.78%)

08:20
09/21/17
09/21
08:20
09/21/17
08:20
Hot Stocks
Lipocine announces motions decision by USPTO »

Lipocine announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

08:20
09/21/17
09/21
08:20
09/21/17
08:20
General news
U.S. initial jobless claims preview: »

U.S. initial jobless…

XLY

Consumer Discretionary Sector SPDR

$89.54

0.3 (0.34%)

08:20
09/21/17
09/21
08:20
09/21/17
08:20
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$56.87

0.2 (0.35%)

08:19
09/21/17
09/21
08:19
09/21/17
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$53.68

-0.4 (-0.74%)

08:19
09/21/17
09/21
08:19
09/21/17
08:19
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$54.60

-0.53 (-0.96%)

08:19
09/21/17
09/21
08:19
09/21/17
08:19
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HKMPY

Hikma

08:18
09/21/17
09/21
08:18
09/21/17
08:18
Conference/Events
Hikma has a conference call hosted by JPMorgan »

JPMorgan Analyst Gordon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

XLV

Health Care Select Sector SPDR

$82.00

0.08 (0.10%)

08:18
09/21/17
09/21
08:18
09/21/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:18
09/21/17
09/21
08:18
09/21/17
08:18
Conference/Events
Cowen to hold a tour »

Vehicles, Vision &…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.